September 3, 2026
SkinIO is proud to be featured in the national Breakthroughs™ Public Service Announcement series, spotlighting our innovative approach to making early skin cancer detection simple, accessible, and connected to care.
The PSA highlights an important challenge in skin cancer prevention: awareness alone isn’t enough if people face barriers to taking the next step. Long appointment wait times, geography, cost concerns, and uncertainty about where to begin can all delay screening and follow-up care.
SkinIO is helping change that.
By combining AI-enhanced skin imaging with rapid Connection to Care™, SkinIO helps people identify potential areas of concern and, when needed, provides a streamlined path to expert dermatology care.
“SkinIO is honored to be featured as one of the breakthrough innovators in this PSA series. The series provides a careful and complete description of our combination of AI-enhanced technology and rapid connection to care, explaining how earlier detection and swift therapy can help reduce the burden of advanced-stage skin cancer.”
— Steve Bonner, CEO, SkinIO
Bonner added, “We welcome continued feedback and conversation and look forward to sharing more about our work to improve access, quality, cost, and outcomes in skin cancer detection and care.”
The national PSA brings greater visibility to SkinIO’s mission to eradicate advanced-stage skin cancer by making early detection simple, accessible, and equitable for all—and reinforces the role that innovative, connected approaches can play in helping more people take action on their skin health.
The Breakthroughs™ series reaches audiences nationwide, including individuals and families, employers, health plans, healthcare organizations, dermatology professionals, and public-health leaders.
Read the full press release here to learn more about SkinIO’s feature in the Breakthroughs™ PSA series and our work to transform access to early skin cancer detection.
